Companies
why Protagonist Therapeutics Inc [PTGX] is a Good Choice for Investors After New Price Target of $41.17
Protagonist Therapeutics Inc [NASDAQ: PTGX] jumped around 3.51 points on Thursday, while shares priced at $28.52 at the close of the session, up 14.03%. The company report on January 31, 2024 at 4:05 PM that Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and
